Login
Navigate Fool.com
Will MACK beat
the market?
Community Rating: 3 Stars: Appealing

4.52 0.02 (0.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.50
Previous Close $4.50
Daily Range $4.41 - $4.65
52-Week Range $2.05 - $7.09
Market Cap $465.7M
P/E Ratio -3.42
Dividend (Yield) $0.00 (0.0%)
Volume 725,593
Average Daily Volume 1,374,363
Current FY EPS -$1.20

How do you think MACK
will perform against the market?

Top MACK Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals

Two clinical-stage cancer companies could provide market-beating returns for risk-tolerant investors.

Notable Two Hundred Day Moving Average Cross - MACK

Today's Biggest Stories in Biotech: Galectin Therapeutics Inc, Merrimack Pharmaceuticals and Nektar

Top stories in biotech and healthcare today.

3 Small Cap Biotechs Developing Novel Cancer Treatments

Three biotechs with pending clinical catalysts for their experimental cancer treatments.

3 New Cancer Treatments to Watch in 2014

New breast cancer treatments from Galena Biopharma, Merrimack Pharmaceuticals, and Pfizer could provide a higher number of patients with better targeted treatments. Here are they key facts you need to know.

Biotech Week in Review

Avanir, Orexigen, XOMA, and Merrimack made biotech headlines last week.

In Insider Trading, a Buy at Merrimack Pharmaceuticals

In Insider Trading, a Buy at Merrimack Pharmaceuticals

Plus, purchases at Wheeler Real Estate Investment Trust and Mattersight.

Sector Update: Biotech Stocks Looking Strong As NASDAQ Struggles

Biotech Week in Review

BioMarin, Orexigen and Merrimack were among the biotech stocks that made headlines last week.

See More MACK News...

Sector

Healthcare

Industry

Drugs

Merrimack Pharmaceuticals, Inc. (MACK) Description

Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases with an initial focus on cancer. Website: http://www.merrimackpharma.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks